Not for human consumption or clinical application
Key Takeaways Peripheral artery disease (PAD) affects 8-12 million Americans and causes leg coldness by reducing blood flow through narrowed arteriesankle-brachial index below 0.9 indicates significant blockage
A medications value depends on clinical evidence, FDA approval status, safety, tolerability, medical history, side-effect risk, and long-term outcomes
10.3390/cells12152012 94 KailasaS
A growing number of large employers are dropping GLP-1 coverage for weight loss heading into 2027, driven by climbing overall health care costs, even as per-unit drug prices have fallen
When you order from our catalogue, your shipment includes free cold-chain express shipping on orders over $250, a batch-specific certificate of analysis, tamper-evident packaging, and dedicated customer support